ARK Genomic Revolution ET... (ARKG)
AMEX: ARKG
· Real-Time Price · USD
23.29
1.02 (4.60%)
At close: Jun 06, 2025, 3:59 PM
23.17
-0.52%
After-hours: Jun 06, 2025, 05:58 PM EDT
4.60% (1D)
| Bid | 23.18 |
| Market Cap | 891.88M |
| AUM | 942.8M |
| NAV | 20.32 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 38.29M |
| Inception Date | Oct 31, 2014 |
| Ask | 23.4 |
| Volume | 3.51M |
| Open | 22.70 |
| Previous Close | 22.27 |
| Day's Range | 22.69 - 23.52 |
| 52-Week Range | 17.50 - 31.16 |
| Holdings | 41 |
| Expense Ratio | 0.75% |
About ARKG
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The companies held in ARKG may be leaders, enablers, or beneficiaries of technologies including:
Asset Class Equity
Ticker Symbol ARKG
Inception Date Oct 31, 2014
Provider ARK
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 60.27% of assets
| Name | Symbol | Weight |
|---|---|---|
| Tempus Ai, Inc. | TEM | 9.57% |
| Crispr Therapeutics ... | CRSP | 8.51% |
| Guardant Health, Inc... | GH | 6.85% |
| Twist Bioscience Cor... | TWST | 6.80% |
| Natera, Inc. | NTRA | 5.84% |
| Recursion Pharmaceut... | RXRX | 5.61% |
| Schrödinger, Inc. | SDGR | 4.90% |
| Adaptive Biotechnolo... | ADPT | 4.28% |
| Caredx, Inc | CDNA | 4.13% |
| Personalis, Inc. | PSNL | 3.78% |
Dividends Dividend Yield 0.64%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 29, 2021 | $0.3824 | Dec 31, 2021 |
| Dec 29, 2020 | $0.7901 | Dec 31, 2020 |
| Dec 27, 2019 | $1.0539 | Dec 31, 2019 |
| Dec 27, 2018 | $0.4663 | Dec 31, 2018 |
| Dec 27, 2017 | $0.3277 | Dec 29, 2017 |
